The best burger in America, according to a health expert
May is National Burger Month and Hims is helping you celebrate with a roundup of the healthiest fast food burgers in the country.
It's also that time of year when many people are working toward various health goals, whether that's getting ready for a summer beach vacation or working on improving overall health and nutrition, so we decided to rank the nation's most popular burgers based on how healthy they are.
While burgers may not come to mind when you think of healthy eating, if you need a quick meal on the go and are craving a burger, some options are definitely healthier than others, and you can still make it work to fit into your meal planning.
What's healthiest for you may be slightly different depending on your health goals, but we partnered with a physician specializing in obesity medicine and SVP of Weight Loss at Hims, Dr. Craig Primack, to determine a methodology that includes a broad nutritional analysis.
Here are the six label categories we looked at as part of the ranking process:
Calories: Consuming excess calories has been linked to obesity and a number of related health conditions, such as cardiovascular disease, diabetes, and even depression. Calories from a fast food burger can quickly add up, so it's important to pay attention to this metric. Protein: Protein is a foundational building block of good health. It increases satiety so you feel full longer while also promoting lean muscle mass and higher metabolism rates.Trans fat: There are many health risks associated with trans fat intake, including cardiovascular disease and fertility issues in both men and women. Saturated fat: Similarly, high saturated fat intake has also been found to contribute to things like cognitive decline and dementia and even lower sperm counts. Net carbs: Not all carbs are bad, but refined carbs (like white burger buns) don't offer the same nutritional value as whole grain carbs. Looking at net carbs accounts for fiber content as well, which can help prevent rapid blood sugar changes.Sugar: Consuming too much sugar can lead to a greater risk of health conditions, such as cardiometabolic disease and dental disease. And in men, it may even reduce semen quality.
Hims looked at the five top burgers on the menus at the most burger chains in the U.S. That excludes some common options like a regular hamburger or cheeseburger from McDonald's, while still capturing most of their bestsellers like the Big Mac and Quarter Pounder with Cheese.
Key Findings
Shake Shack dominates with three out of the top four healthiest burgers. These burgers also had the least amount of net carbs.The burgers with the most calories also tended to be the burgers with the most protein, which can complicate the health equation.Some double and bacon burgers rank well thanks to higher protein and lower sugar and carb content.
Top 10 Healthiest and Unhealthiest Fast Food Burgers
It's here: the 10 best fast food burgers to help you be mindful of your health and weight loss diet goals while still treating yourself to your drive-thru favorites.
1. Freddy's Double Steakburger (Freddy's Frozen Custard & Steakburgers)
2. SmokeShack (Shake Shack)
3. Avocado Bacon Burger (Shake Shack)
4. ShackBurger (Shake Shack)
5. Double SONIC Smasher (SONIC Drive-In)
6. Freddy's Original Bacon and Cheese Double (Freddy's Frozen Custard & Steakburgers)
7. Double-Double (In-N-Out Burger)
8. ButterBurger (Culver's), McDouble (McDonald's), and Triple SONIC Smasher (SONIC Drive-In)-TIED
Fast Food Burgers Ranked by Nutritional Value
1. Freddy's Double Steakburger (Freddy's Frozen Custard & Steakburgers)
2. SmokeShack (Shake Shack)
3. Avocado Bacon Burger (Shake Shack)
4. ShackBurger (Shake Shack)
5. Double SONIC Smasher (SONIC Drive-In)
6. Freddy's Original Bacon and Cheese Double (Freddy's Frozen Custard & Steakburgers)
7. Double-Double (In-N-Out Burger)
8. ButterBurger (Culver's), McDouble (McDonald's), and Triple SONIC Smasher (SONIC Drive-In)-TIED
11. Mushroom & Swiss (Culver's)
12. Hamburger (In-N-Out Burger)
13. ButterBurger Cheese (Culver's)
14. California Style Double (Freddy's Frozen Custard & Steakburgers) and Cheeseburger (In-N-Out Burger)-TIED
16. Double ShackBurger (Shake Shack) and Prime Rib Steak Burger (Freddy's Frozen Custard & Steakburgers)-TIED
18. Cheesy Bacon SuperSONIC Stack (SONIC Drive-In)
19. The Culver's Bacon Deluxe (Culver's)
20. Cheesy Bacon SONIC Stack (SONIC Drive-In)
21. The Culver's Deluxe (Culver's)
22. Big Mac (McDonald's)
23. Son of Baconator (Wendy's)
24. Original Cheeseburger Signature Stackburger (Dairy Queen) and Quarter Pounder with Cheese (McDonald's)-TIED
26. Bacon & Cheese Whataburger (Whataburger) and Dave's Single (Wendy's)-TIED
28. Shack Stack (Shake Shack)
29. Jalapeno & Cheese Whataburger (Whataburger)
30. Hardee's Frisco (Hardee's)
31. Whopper (Burger King)
32. Whataburger (Whataburger)
33. Grilled Cheese Steakburger Double Patty (Freddy's Frozen Custard & Steakburgers)
34. Double Whopper (Burger King) and FlameThrower Signature Stackburger (Dairy Queen)-TIED
36. Bacon Ultimate Cheeseburger (Jack in the Box)
37. Garlic Butter Bacon Cheeseburger (SONIC Drive-In)
38. Double Meat Whataburger (Whataburger)
39. Bacon Cheese Deluxe Signature Stackburger (Dairy Queen)
40. Double Quarter Pounder with Cheese (McDonald's) and Single Western Bacon Cheeseburger (Carl's Jr.)-TIED
42. Quarter Pounder with Cheese Deluxe (McDonald's)
43. Baconator (Wendy's) and Bacon Burger (Five Guys)-TIED
45. Hamburger (Five Guys)
46. Bacon Cheeseburger (Hardee's) and Dave's Double (Wendy's)-TIED
48. Steakhouse Bacon Whopper (Burger King)
49. California Classic Double Cheeseburger (Carl's Jr.)
50. Single Famous Star (Carl's Jr.)
51. Bacon Cheeseburger (Five Guys)
52. Triple Smoky BBQ Bacon Buford (Checkers and Rally's)
53. Two Cheese Deluxe Signature Stackburger (Dairy Queen)
54. Baconzilla! (Checkers and Rally's)
55. Bacon Double Smashed Jack (Jack in the Box)
56. Triple Whopper (Burger King)
57. Famous Star (Hardee's)
58. Dave's Triple (Wendy's)
59. Cheeseburger (Five Guys)
60. Double Hardee's Frisco (Hardee's)
61. Big Buford (Checkers and Rally's)
62. Smoky BBQ Bacon Buford (Checkers and Rally's)
63. Big Angus Famous Star (Carl's Jr.) and Triple Meat Whataburger (Whataburger)
65. Double Western Bacon Cheeseburger (Carl's Jr.)
66. Super Star (Hardee's)
67. Bacon King (Burger King)
68. Backyard Bacon Ranch Signature Stackburger (Dairy Queen)
69. Classic Smashed Jack (Jack in the Box)
70. Triple Big Buford (Checkers and Rally's)
71. Bacon & Swiss Buttery Smashed Jack (Jack in the Box)
72. Buttery Smashed Jack (Jack in the Box)
Get the data
Fast Food Burger Trends Revealed
Stick to your personal goals by looking at the best and worst burgers in each nutrition category.
Which Fast Food Burgers Have the Most Protein?
Bigger burgers mean more protein, which can help meet your daily nutrition goals. Just keep an eye out for higher calorie counts.
Fast Food Burgers With the Most Protein
Bacon King (Burger King): 107.4 gramsTriple Whopper (Burger King): 72.5 gramsDave's Triple (Wendy's): 70 grams
Fast Food Burgers With the Least Protein
Hamburger (In-N-Out Burger): 16 gramsButterBurger (Culver's) and Cheeseburger (In-N-Out Burger): 20 grams McDouble (McDonald's): 22 grams
Which Fast Food Burgers Have the Most Calories?
The burgers with the most protein are also the highest in calories, another important metric to be mindful of.
Fast Food Burgers With the Most Calories
Bacon King (Burger King): 1710 caloriesTriple Whopper (Burger King): 1170 caloriesDave's Triple (Wendy's): 1160 calories
Fast Food Burgers With the Least Calories
Hamburger (In-N-Out Burger): 360 caloriesButterBurger (Culver's) and McDouble (McDonald's): 390 calories Cheeseburger (In-N-Out Burger): 430 calories
Which Fast Food Burgers Have the Most Trans Fat?
Some burgers have quite high trans fat content, but five options have none at all.
Fast Food Burgers With the Most Trans Fat
Bacon Double Smashed Jack (Jack In the Box) and Dave's Triple (Wendy's): 4.5 gramsBaconator (Wendy's), Bacon Ultimate Cheeseburger (Jack In the Box), Dave's Double (Wendy's), Double Hardee's Frisco (Hardee's), and Super Star (Hardee's): 3 gramsBacon King (Burger King): 2.8 grams
Fast Food Burgers With No Trans Fat
Cheeseburger (In-N-Out Burger), Cheesy Bacon SONIC Stack (SONIC Drive-In), Cheesy Bacon SuperSONIC Stack (SONIC Drive-In), Double-Double (In-N-Out Burger), Hamburger (In-N-Out Burger)
Which Fast Food Burgers Have the Most Net Carbs?
The amount of carbs in a burger bun can vary greatly. The BigMac, for instance, is famous for its third bun yet it doesn't appear in the top three list of burgers with the most net carbs. This metric also likely drove the Avocado Bacon Burger, ShackBurger, and SmokeShack burger to the top of our overall list of healthy options.
Fast Food Burgers With the Most Net Carbs
Double Western Bacon Cheeseburger (Carl's Jr.): 74 gramsSingle Western Bacon Cheeseburger (Carl's Jr.): 73 gramsSteakhouse Bacon Whopper (Burger King): 60 grams
Fast Food Burgers With the Least Net Carbs
Avocado Bacon Burger and ShackBurger (Shake Shack): 26 gramsDouble ShackBurger (Shake Shack): 27 gramsSmokeShack (Shake Shack): 28 grams
Methodology: How Scores Were Calculated
To determine the healthiest burgers in America, Hims evaluated menus from the country's top burger chains based on 2024 revenue. The fast food restaurants included in the analysis were McDonald's, Wendy's, Burger King, SONIC Drive-In, Jack in the Box, Whataburger, Culver's, Five Guys, Hardee's, Carl's Jr., In-N-Out Burger, Shake Shack, Checkers and Rally's, and Freddy's Frozen Custard & Steakburgers.
Hims evaluated up to five burgers on each restaurant's permanent menu (as available) based on the following nutrition metrics: calories, protein, trans fat, saturated fat, net carbs, and sugar. We used a 2x multiplier for calories and trans fat and a 3x multiplier for protein.
3 Ways to Keep Your Burger Meal As Healthy As Possible
Before you place your order, consider making a few alterations to maximize the nutritional content of your meal.
Make your calories count. Not all calories are created equally, so if you're on a weight loss journey aim for your personal target calorie count by choosing more nutritious ingredients in your meal. For instance, a double burger, which has more protein content, would be a better choice than fries and a single burger. (Wondering how much protein you need? Check out this protein calculator.) Also watch for hidden ingredients lurking in burgers, such as higher sugar count and carbs in buns. For instance, some restaurants report adding high fructose corn syrup to buns for extra sweetness.Opt for a healthier side. Instead of making a meal with fries as your side, consider getting a salad or fruit slices instead. French fries are high in fat, oil, and salt, all of which decrease the overall nutritional profile of this fast food staple. Just be mindful of sneaky calories and sugar content in the salad dressing.Grab a low-calorie drink. You can find a wide variety of drink options when you grab a burger at a fast food restaurant, but adding a high-sugar drink can add a lot of calories to your meal. Water is, of course, the healthiest option, but an unsweetened iced tea or the occasional diet soda are also better options. If you're craving a soda, sparkling water can also be a satisfying option.
This story was produced by Hims and reviewed and distributed by Stacker.
© Stacker Media, LLC.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
7 hours ago
- Forbes
Veterinary Telehealth Company Dutch Is Transforming Pet Care Access
With tools powered by OpenAI and Google Gemini, Dutch cuts admin time by 75%, doubling daily patient volume while giving vets their time—and sanity—back. Dutch Founder & CEO Joe Spector with his dog Eddie, a 5-year-old corgi Joe Spector co-founded Hims, helped take it public, and built a billion-dollar telehealth brand. His second act? Turning pet care on its head. Dutch is a veterinary telehealth platform built to modernize how care is delivered and accessed across the U.S. With Dutch, the nationwide veterinary telehealth platform he launched in 2021, Spector is building a tech-first challenger to a stubbornly analog industry—one defined by burnout, access gaps, and high costs. His mission is personal: After a $4,000 urgent care bill when his dog ate a few chocolate M&Ms, Spector, who grew up in a low-income Russian immigrant household living on welfare, realized most families wouldn't be able to afford a single $200 vet visit. "In modest households like the one I grew up in, spending hundreds on a pet's care just isn't an option," he says. "Dutch exists to democratize access—and make it radically more affordable." This week, Dutch unveiled a suite of AI tools designed to combat one of veterinary medicine's biggest problems: administrative overload. Integrated into Dutch's proprietary EMR and powered by OpenAI and Google Gemini, the system reduces documentation time from 20 minutes to five—enabling vets to see twice as many pets per day. The AI features span the full care journey: pre-visit summaries, live transcription, treatment plan generation, and personalized product recommendations. It's not just smarter—it's designed to be scalable. "It's transforming our consults and our teams," says Spector. "And it's just the beginning." Dutch is now operational in all 50 states, with prescribing capabilities in 34. Since launch, the company has logged over 700,000 virtual visits, expanded into Rx delivery, and treats more than 150 conditions. Memberships start at $15/month and provide unlimited access to licensed vets. Dutch also recently partnered with Ancestry to launch a DNA-based personalized dog health product, and with PetMeds to help the 50% of pet parents without a primary vet get timely access to prescriptions. Dutch-PetMeds partnership helps the 50% of pet parents without a primary vet get timely access to ... More prescriptions. Joe's connection to pet care runs deep—and personal. 'When I was young, our family had a Rottweiler,' he recalls. 'It was a very anxious dog. That was my first experience seeing how much behavioral issues can affect a pet's—and a family's—well-being.' That early exposure shaped Spector's conviction that understanding a dog's temperament and behavioral predispositions is as essential as treating physical ailments. It's part of why Dutch emphasizes behavioral health, and why its latest tools—like AI-powered care plans and DNA-based trait analysis—aim to give pet parents a fuller picture of their animal's needs. The pet health space is attracting venture capital, with players like: These companies primarily assist existing clinics. Dutch, by contrast, has raised $43 million from Forerunner Ventures, Eclipse Ventures, and Bling Capital to build a full-stack, AI-first telehealth platform—including its own EMR, prescription infrastructure, and direct-to-consumer membership model. "Everyone else is building tools for the old model," says Spector. "We're building the new one." Dutch's 2025 State of Online Veterinary Care report reveals that: Veterinarians earn around $120,000 annually, yet most clinics rely heavily on product sales—up to one-third of their revenue. Spector sees Dutch as a more consumer-aligned alternative to the legacy, clinic-first model. "The vet industry's a cash business built for clinic owners, not for scale," he says. States like California, Arizona, and Florida have expanded telemedicine access. And in a landmark decision, the Fifth Circuit Court of Appeals ruled in favor of veterinary telemedicine, quipping: 'If it's good for Uncle Bernard, shouldn't it be good for your St. Bernard?' "Telemedicine doesn't replace in-person care—it expands it," says Spector. "We bring people into the system who otherwise wouldn't go at all." Veterinary telemedicine revenue is projected to exceed $10 billion by 2030. Dutch's roadmap includes agentic task automation, image-based triage, and exploration of longevity drugs like rapamycin. The platform also aims to alleviate workforce stress, with tools built to reduce—not increase—provider burnout. Meanwhile, rising care costs are becoming a barrier to pet ownership. A recent Epoch Times article, citing the American Pet Products Association, noted that in 2025, U.S. pet spending will reach $157 billion—with $41.4 billion spent on veterinary care alone. For retirees and low-income families, the financial burden could discourage pet adoption altogether. Pet care is also a mental health issue. Half of U.S. adults report feeling lonely, and studies show that those who are chronically lonely are 40% more likely to die within four years. The risk rises to 75% for people who are socially isolated. Owning a dog has been shown to significantly reduce loneliness and social isolation, offering emotional connection, structure, and purpose. Dutch's mission is rooted in making that bond possible—for more people—by providing affordable, ongoing access to care. Joe Spector has already helped build one unicorn. With Dutch, he's chasing something bigger: a category-defining veterinary telehealth platform using AI to deliver smarter, more affordable care. "This is a once-in-a-generation opportunity to rebuild pet care from the ground up," he says. "We want to go public—and rule the world."
Yahoo
10 hours ago
- Yahoo
Analysis-Hims & Hers says its weight-loss business can grow as US market changes
By Amina Niasse (Reuters) -Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some analysts see a need for the online website to adjust to changing competition in the U.S. Hims has thrived in the market for cheaper compounded versions of highly in-demand weight-loss drugs, such as Novo Nordisk's Wegovy. This was allowed by the U.S. Food and Drug Administration when those drugs were in shortage. But with the end of supply constraints, the agency said sales of compounded versions had to stop by May 22. 'With the semaglutide shortage declared over, Hims now has to transition its model to generate growth from other products within its broad weight-management program,' said Michael Cherny, a healthcare analyst at Leerink, using the chemical name for Wegovy as well as Novo's Ozempic and Rybelsus. Hims shares fell 14% in the week after the FDA's deadline and are down around 18% from a peak in February. Hims said it is now selling "personalized" dosages of Wegovy, starting at around $165 a month, under rules allowing it for clinical reasons such as decreased side effects. Hims also sells liraglutide, a generic version of an older Novo diabetes drug that also causes weight loss, as well as branded Wegovy and Eli Lilly's rival Zepbound. But analysts question whether the offerings actually qualify as "personalized" and say it is unclear if Novo, which has said mass production of copies is breaking the law, will allow it. Instead, they say, Hims should pivot to work with insurers, something a company spokesperson said it has no plans to do. Hims rivals Ro and Noom, which also describe compounded products as personalized, do work with insurers. CVS Health and Cigna announced new strategies for weight-loss drugs, by limiting which it will cover or out-of-pocket costs. Leerink's Cherny said any expansion of insurance coverage for the drugs would lessen the need for cash-pay vendors and compounders, stymying Hims' growth. Hims could miss growth targets if customers go elsewhere, he said. The company has targeted revenue of $6.5 billion by 2030. Analysts are forecasting Hims 2025 revenue of $2.4 billion, up from $1.5 billion in 2024, and earnings of 65 cents a share, according to LSEG data. WORKING WITH NOVO Hims CEO Andrew Dudum told investors last month that many consumers choose cash-pay options because their insurance deductibles for the weight-loss drugs are too high. He said the company is targeting these so-called under-insured consumers and plans to offer more personalized products after purchasing a diagnostic lab that can help identify potential new patients for its service. New offerings include low testosterone and menopause treatments. It is also expanding in the UK and Europe. Hims's plans to keep selling compounded versions of semaglutide could complicate a new partnership that allows its subscribers to access Novo Nordisk's direct-pay pharmacy called NovoCare, two analysts and an investor told Reuters. Truist analyst Jailendra Singh said it could provoke more litigation or Novo ending the agreement. The Danish drugmaker has filed nearly 120 lawsuits across 34 U.S. states against companies it says are unlawfully selling knockoffs of its drugs. Hims began selling compounded semaglutide in May of 2024, according to financial filings. In the first quarter of 2025, it projected sales of at least $725 million from all drugs that target the GLP-1 protein, the class to which Wegovy and Zepbound as well as Lilly's Mounjaro belong. Hims sells compounded semaglutide at about one-third of Wegovy's list price, but those purchases don't count against insured patients' deductibles, which can run to the thousands of dollars. Patient co-pays vary by each plan but can run from a set amount to a percentage of the list price of around $1,000. Cigna's Express Scripts, one of the big three U.S. pharmacy benefit managers, struck a deal last month in which patients will be able to buy branded Wegovy for a $200 co-pay, pricing it said was aimed at the cash-pay market. CVS's Caremark PBM made Wegovy its preferred weight-loss drug offering starting July 1. It said the move reflected lower pricing from Novo that it hopes will help add health plan clients for whom weight-loss coverage was too pricey. Hims offered compounded semaglutide for as low as $99 a month in September to some qualifying people. "If you want to be a real one-shop stop on different healthcare needs, you want to give people choices," said Singh. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock?
Hims & Hers stock is on the upswing after the company secured a weight-loss drug partnership. Hims & Hers is acquiring its way into Europe and wants to build more personalized drugs for its telehealth customers. Shares have soared, but still have a ton of potential for patient long-term shareholders. 10 stocks we like better than Hims & Hers Health › Many companies have failed to disrupt the complicated U.S. healthcare market. Hims & Hers (NYSE: HIMS) may finally be succeeding in cracking the code. The online telehealth platform focuses on circumventing the insurance market; its business of selling affordable medications directly to individuals is growing like a weed, and expects to generate $6.5 billion in revenue by 2030. It has had a tumultuous start to 2025, as Hims & Hers waged a battle to sell new weight loss medications on its online marketplace. Now, with momentum back on its side, the stock is up 118% year to date and 446% in the last five years. Let's take a deeper look at this company, and see whether you might want to buy Hims & Hers stock for your portfolio now. Hims & Hers' model is simple. It has two separate web platforms -- Hims for men and Hers for women -- that sell medications and deliver to customers' front doors. It began with sexual health, but has moved into dermatology, hair loss, mental health, and now weight loss medications. A key to its success has been avoiding the insurance market with products that don't break the bank. Customers loathe dealing with health insurers in the United States, and sometimes would rather not use insurance at all. Plus, some of these products aren't covered by insurance. This strategy has helped the company close in on over $2 billion in projected revenue in 2025. To keep up this impressive growth, Hims & Hers wants to offer weight loss medications, which have been a blockbuster set of drugs for the pharmaceutical market. For a while the popularity of these drugs, such as Novo Nordisk's Wegovy, left them in short supply; that allowed third parties such as Hims & Hers to produce them as a compounding pharmacy and sell them at much cheaper prices. This ended up generating $200 million of Hims & Hers' $1.4 billion in 2024 revenue. But with the shortage of Wegovy over and the compounding pharmacy exception ended, the company's weight-loss business was at a major turning point. Luckily, at the end of April Hims & Hers announced a partnership with Novo Nordisk that seems to resolve this issue: It gives Hims & Hers the ability to sell Wegovy directly on its platform. Hims & Hers is not an exclusive supplier of the drug -- or any drugs on its marketplaces, to be fair -- but it hopes to use its subscription business model, marketing expertise, and simplified user proposition to drive sales for Novo Nordisk in the huge obesity-care market. Besides weight loss drugs, Hims & Hers has more ambitions to reach its goal of $6.5 billion in revenue by 2030. Just recently, the company announced its intent to acquire European competitor Zava so it could expand its telehealth service to Europe. The acquisition will add a platform with 1.3 million active customers in the U.K., Germany, France, and Ireland. It makes sense that Hims & Hers can supercharge growth for the platform with its plethora of medications offered to customers, keen marketing skills, and subscription-based selling model. Over the long run, Hims & Hers aims to make healthcare for its customers more personalized. This includes unique drug combinations, its own outsourcing facility, and at-home testing capabilities. Details remain sparse, but the vision is clear: disrupting more and more of the trillions of dollars spent on healthcare by building a business that people actually enjoy interacting with. This is why 2.4 million active customers use Hims & Hers today. A revenue goal of $6.5 billion seems well within reach by 2030. Hims & Hers is only at 2.4 million active customers, and there are tens of millions of people in the United States alone who could start using or switch to one of its telehealth platforms. Add on the Zava acquisition in Europe, and the runway for growth gets even larger. The company has an impressive gross profit margin of 77%, which should lead to high levels of profitability at scale. On $6.5 billion in future revenue, it could very well post a net profit margin of over 20%, and achieve $1.5 billion in bottom-line profits and free cash flow. A 20% profit margin is easily achievable because of its high gross margins and the fact it currently spends 40% of revenue on marketing today, a figure that has come down over time and should come down even more as Hims & Hers keeps scaling. However, Hims & Hers has played fast and loose with laws and regulations in the past. It sold weight loss drugs when the legality of doing so was unclear, and although that dispute seems to have been resolved, management could easily start playing with fire again and burn its reputation as a trusted provider of medications. Otherwise, this looks like a fantastic growth stock that just doubled its addressable market with the Zava acquisition. Today, Hims & Hers has a market cap of $12.3 billion. You might think it's overvalued because of the stock's recent run-up in price, but the numbers show that patient investors could be rewarded by holding for the long term. A $12.3 billion market cap is only around 8 times my 2030 earnings estimate of $1.5 billion, which would be a dirt cheap price-to-earnings (P/E) ratio for a fast-growing company compared to the current market cap. Most likely, the stock will be valued at a higher multiple than 8, meaning that the stock will be higher in five years. It doesn't come without risks, but if you're a growth investor, you might love Hims & Hers stock for its long-term potential. Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 173% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Brett Schafer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
